Puma Biotechnology Inc (NASDAQ: PBYI) stock slightly rises post weakness
Puma Biotechnology Inc (NASDAQ: PBYI) stock fell 8.12% on April 1st, 2019 after the company and Pierre Fabre have signed an exclusive license agreement under…
Puma Biotechnology Inc (NASDAQ: PBYI) stock fell 8.12% on April 1st, 2019 after the company and Pierre Fabre have signed an exclusive license agreement under…
Puma Biotechnology Inc(NASDAQ: PBYI) stock lost over 11.2% on November 9th after-hours session given their weak bottom line. For the third quarter of 2017, the…